医学
累积发病率
入射(几何)
食管
发育不良
巴雷特食管
食管腺癌
内窥镜检查
食道疾病
外科
公共卫生
医疗保健
库苏姆
风险评估
流行病学
相对风险
公共卫生监督
急诊医学
马尔可夫模型
疾病监测
质量调整寿命年
作者
Jin Lin Tan,J. P. Chan,Mohamed Asif Chinnaratha,Kelvin Bryan Tan,Rajvinder Singh
出处
期刊:Endoscopy
[Thieme Medical Publishers (Germany)]
日期:2026-02-27
卷期号:58 (08): 821-830
被引量:3
摘要
Background: Artificial intelligence (AI) has emerged as a promising tool to detect early dysplasia in Barrett's esophagus (BE). However, the cost-effectiveness of AI-assisted BE surveillance has not been evaluated. Methods: A Markov model simulated 1000 Australian individuals with nondysplastic Barrett's esophagus (NDBE) undergoing surveillance from age 50 to 80 years, with follow-up until age 100. We compared AI-assisted surveillance with targeted biopsies against standard endoscopy with four-quadrant biopsies under 3-yearly and 5-yearly surveillance. The primary outcome was the incremental cost-effectiveness ratio (ICER). Secondary outcomes included cumulative incidence of high grade dysplasia (HGD)/T1 lesions and advanced esophageal adenocarcinoma (EAC), as well as their relative differences. A health care system perspective was employed, with costs and utilities discounted at an annual rate of 3%. Results: AI-assisted surveillance was cost effective across both intervals, with ICERs of AUD 14 039/quality-adjusted life year (QALY) (3-yearly) and 3609/QALY (5-yearly). Compared with standard surveillance, AI reduced the cumulative incidence of advanced EAC by 5 and 3 cases per 1000 people (relative reductions of 3.5% and 1.6%) for 3- and 5-yearly surveillance, respectively. Conversely, AI increased HGD/T1 detection by 27 and 38 cases per 1000 people (relative increases of 21.8% and 27.7%) for 3- and 5-yearly surveillance, respectively. Additionally, AI reduced missed HGD/T1 incidence by 37 and 45 cases per 1000 people (relative reductions of 72.9% and 72.2%) for 3- and 5-yearly surveillance, respectively. Conclusion: AI-assisted endoscopic surveillance in BE was a cost-effective strategy in the Australian health care setting, reducing the cumulative incidence of advanced EAC and missed HGD/T1 lesions.
科研通智能强力驱动
Strongly Powered by AbleSci AI